<?xml version="1.0" encoding="UTF-8"?>
<doi_batch version="4.4.2" xmlns="http://www.crossref.org/schema/4.4.2" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xsi:schemaLocation="http://www.crossref.org/schema/4.4.2 http://www.crossref.org/schema/deposit/crossref4.4.2.xsd">
<head>
<doi_batch_id>bc556b61902ae3de06-63cb</doi_batch_id>
<timestamp>20240702085527838</timestamp>
<depositor>
  <depositor_name>sayedhussain.mosawi@ghalib.edu.af:6ukb</depositor_name> 
  <email_address>sayedhussain.mosawi@ghalib.edu.af</email_address>
</depositor>
<registrant>WEB-FORM</registrant> 
</head>
<body>
<journal>
<journal_metadata>   <full_title>Afghanistan Journal of Infectious Diseases</full_title>   <abbrev_title>AJID</abbrev_title>   <issn media_type='electronic'>29596491</issn>   <doi_data>     <doi>10.60141/1</doi>     <resource>https://www.ajid.ghalib.edu.af/index.php/ajid</resource>   </doi_data> </journal_metadata> <journal_issue>  <publication_date media_type='print'>     <month>07</month>     <day>01</day>     <year>2024</year>   </publication_date>  <publication_date media_type='online'>     <month>07</month>     <day>01</day>     <year>2024</year>   </publication_date>   <journal_volume>     <volume>2</volume>   </journal_volume>   <issue>2</issue>   <doi_data>     <doi>10.60141/AJID/V.2.I.2</doi>     <resource>https://www.ajid.ghalib.edu.af/index.php/ajid/issue/view/11</resource>   </doi_data> </journal_issue><!-- ============== --> <journal_article publication_type='full_text'>   <titles>     <title>Integrating molecular docking and molecular dynamics simulation approaches for investigation of the affinity and interactions of quercetin with Class D beta-lactamase, OXA-10</title>   </titles>   <contributors>      <organization sequence='first' contributor_role='author'>. Medical Sciences Research Center, Ghalib University, Kabul, Afghanistan</organization>    <person_name sequence='first' contributor_role='author'>      <given_name>Fardeen</given_name>      <surname>Mohammadi</surname>    </person_name>    <person_name sequence='additional' contributor_role='author'>       <given_name>Abdul Musawer </given_name>       <surname>Bayan</surname>     </person_name>     <organization sequence='additional' contributor_role='author'>. Medical Sciences Research Center, Ghalib University, Kabul, Afghanistan</organization>     <person_name sequence='additional' contributor_role='author'>       <given_name>Abdul Wakil</given_name>       <surname>Qarluq</surname>     </person_name>     <organization sequence='additional' contributor_role='author'>. Medical Sciences Research Center, Ghalib University, Kabul, Afghanistan</organization>   </contributors>    <jats:abstract xml:lang='en'>         <jats:p>Introduction: The misuse of β-lactam antibiotics has led to the development of β-lactamase-producing organisms, which inhibit β-lactam activity by hydrolyzing the peptide bond. This study aims to investigate the inhibitory effect of quercetin, a natural composite and isoquinoline alkaloid, on β-lactamase enzyme action, potentially increasing antibiotic effectiveness. Materials and Methods: This study utilized computational techniques like molecular docking and MD simulation to predict the binding mode and possible conformation poses of quercetin with the OXA-10 β-lactamase enzyme. Autodock software was used for docking, while Gromacs 2019.6 package was used for MD simulations to study molecular complex behavior over time. Results: The outcomes of the molecular docking analysis revealed a favorable interaction between quercetin and the OXA-10 β-lactamase enzyme, as evidenced by a binding energy of -5.95 kcal/mol and a suitable binding mode. MD simulations confirmed the docking results, showing stable hydrogen bonds between Quercetin and OXA-10, as well as comparable RMSD, RMSF, SASA values, and other parameters.  Discussion: This research shows the potential of quercetin, a natural compound with multiple medicinal effects, as a possible inhibitor of the class D type β-lactamase OXA-10. Therefore, this study maintains valuable intuition for designing new inhibitors of antimicrobial resistance to combat β-lactamase activity.</jats:p>     </jats:abstract> <publication_date media_type='print'>     <month>07</month>     <day>01</day>     <year>2024</year>   </publication_date> <publication_date media_type='online'>     <month>07</month>     <day>01</day>     <year>2024</year>   </publication_date>   <pages>     <first_page>19</first_page>     <last_page>26</last_page>   </pages>   <doi_data>     <doi>10.60141/AJID/V.2.I.2/3</doi>     <resource>https://www.ajid.ghalib.edu.af/index.php/ajid/article/view/56</resource>   </doi_data> </journal_article>
</journal>
</body>
</doi_batch>
